Dark
Light
Today: June 9, 2024
May 27, 2024
1 min read

Conexus Venture Capital doubles down on Saskatchewan tech ecosystem commitment


TLDR:

Conexus Venture Capital Inc. has announced the launch of CVC Fund #2, a new venture capital fund focused on backing high-growth tech companies in Saskatchewan. The fund aims to raise $30 million and has secured an initial investment of $15 million from Conexus Credit Union. This fund is part of Conexus’ commitment to supporting Saskatchewan startups and boosting the province’s economy.


Conexus Venture Capital Inc. has launched a new venture capital fund, CVC Fund #2, with the goal of backing Saskatchewan’s top high-growth tech companies.

  • The fund aims to raise $30 million and has received an initial investment of $15 million from Conexus Credit Union.
  • The launch of CVC Fund #2 is a part of Conexus’ dedication to supporting Saskatchewan startups and stimulating the province’s economy.

Conexus Credit Union and Conexus Venture Capital Inc. have announced the launch of CVC Fund #2, a new venture capital fund hyper focused on backing Saskatchewan’s top high-growth tech companies. The ambitious fund is aiming to raise $30 million. CVC Fund #2 has secured an initial investment of $15 million from Conexus because of the credit union’s dedication to propelling Saskatchewan startups and supporting the province’s economy.

Jordan McFarlen, Managing Director of Conexus Venture Capital Inc. stated, “We’re doubling down on our commitment to the Saskatchewan tech ecosystem.” He believes in the founders of the province and their ability to make breakthroughs globally.

Since the launch of Conexus Venture Capital Inc. in 2019, they have facilitated the investment of $66 million into helping businesses grow, with 13 based in the province. The investment in CVC Fund #2 signals Conexus Credit Union’s commitment to championing a thriving Saskatchewan.


Previous Story

Shipzero Raises €8Million for Logistics Emissions Management Platform

Next Story

Nectero scores clinical trial investment for groundbreaking biotech breakthrough

Latest from Blog

Go toTop